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Study on immune proteins in domesticated and wild silkmoths Bombyx mori and Antheraea mylitta, respectively, led to identification
of a new class of antimicrobial proteins. We designated them as lysozyme-like proteins (LLPs) owing to their partial similarity with
lysozymes. However, lack of characteristic catalytic amino acid residues essential for muramidase activity in LLPs puts them functionally
apart from classical lysozymes. Two LLPs, one from B. mori (BLLP1) and the other from A. mylitta (ALLP1) expressed in a recombinant
system, exhibited a broad-spectrum antibacterial action. Further investigation of the antibacterial mechanism revealed that BLLP1 is
bacteriostatic rather than bactericidal against Escherichia coli and Micrococcus luteus. Substantial increase in hemolymph bacterial load
was observed in B. mori upon RNA interference mediated in vivo knockdown of BLLP1. We demonstrate that the antibacterial
mechanism of this protein depends on peptidoglycan binding unlike peptidoglycan hydrolysis or membrane permeabilization as observed
with lysozymes and most other antimicrobial peptides. To our knowledge, this is the first report on functional analysis of novel, non-
catalytic lysozyme-like family of antibacterial proteins that are quite apart functionally from classical lysozymes. The present analysis
holds promise for functional annotation of similar proteins from other organisms.
r 2007 Elsevier Ltd. All rights reserved.
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The immune repertoire in insects comprises mainly of the
innate mechanisms, manifested by both cellular and
humoral defense mechanisms though recent evidences
suggest the presence of adaptive responses as well (Dong
et al., 2006; Sadd and Schmid-Hempel, 2006; Watson et al.,
2005). The highlight of the humoral defense is a rapid
release of different types of antimicrobial peptides (AMPs)
in the insect hemolymph within few hours upon infection.
Collectively, these AMPs are known to mount an effective
immune defense against invading pathogens (Yamakawa
and Tanaka, 1999). Lysozyme is a widespread AMP
occurring in insects, vertebrates, plants and microorgan-
isms. Lysozymes are muramidases that hydrolyse the b-1,4-e front matter r 2007 Elsevier Ltd. All rights reserved.
mb.2007.03.013
ing author. Tel.:+91 40 2715 1344; fax:+9140 2715 5610.
ess: jnagaraju@cdfd.org.in (J. Nagaraju).glycosidic linkage in the N-acetyl glucosamine and N-acetyl
muramic acid residues in the peptidoglycan layer of the
bacterial cell and cause their lysis. Lysozymes are
upregulated upon infection in the lepidopteran insects
unlike their constitutively expressed vertebrate counter-
parts (Daffre et al., 1994).
A c-type lysozyme has been previously characterized
from the domesticated and wild silkmoths, Bombyx mori
and Antheraea mylitta, respectively (Jain et al., 2001; Lee
and Brey, 1995). In the present study, we report novel
AMPs from the two silkworm species from which we have
previously characterized c-type lysozymes. These novel
proteins are unique in that they share 50–60% similarity at
the amino acid level with the c-type insect lysozymes but
lack characteristic catalytic activity of peptidoglycan
hydrolysis exhibited by lysozymes. Hence we chose to
designate them as lysozyme-like proteins (LLPs). Never-
theless, we found, these LLPs exhibit profound antibacter-
ial activity towards a wide range of gram-positive and
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infection. An immune related function is thereby suggested.
Further, the in vivo RNA interference (RNAi) mediated
knockdown of B. mori lysozyme-like protein 1 (BLLP1)
resulted in an enhanced bacterial load in hemolymph. We
further demonstrated that BLLP1 exhibits bacteriostatic
effects against Escherichia coli and Micrococcus luteus and
the inhibition was rescued when peptidoglycan was added
externally. These results tempt us to hypothesize that the
mechanism of inhibition is related to binding of peptido-
glycan by BLLP1, leading to growth inhibition rather than
hydrolysis of peptidoglycan or membrane permeabiliza-
tion. To the best of our knowledge this is the first report on
natural occurrence of non-bacteriolytic, antibacterial LLPs
that adds yet another novelty to the already existing
diversity of AMPs.2. Materials and methods
2.1. Isolation of LLP and lysozyme cDNAs
A. mylitta lysozyme (AL) cDNA was isolated by
designing primers based on the protein sequence reported
earlier (Jain et al., 2001) and cDNA clone of B. mori
lysozyme (Lee and Brey, 1995) was a kind gift from Paul
Brey. Partial sequence of A. mylitta lysozyme-like protein 1
(ALLP1) was identified from an E. coli-challenged fat body
EST library (Gandhe et al., 2006) and subsequently the full
length sequence was obtained by 50 RACE PCR using the
50 RACE kit (Clontech). The 50 end sequence was amplified
by using an adaptor primer and a reverse gene specific
primer. PCR was performed for 25 cycles on an eppendorf
master cycler. A 650 bp band was isolated, sequenced and
confirmed to be 50 ALLP1 sequence. BLLP1 was identified
from Silkbase (Mita et al., 2003) by BLAST search analysis
with ALLP1 as a query. BLLP2 and BLLP3 were identified
by tBLASTx analysis at SilkDB with BLLP1 as a query
sequence (Wang et al., 2005). Primers were designed by
Primer-3 software (Rozen and Skaletsky, 2000) and their
sequences were as follows:
(50–30)-AL Forward (F)-AAACGTTTCACCAGATG-
CG, AL Reverse (R)-ACAGTCGCTAATATCTGG;
BL F-AAAACGTTCACGAGATGCG, BL R-GCAG-
CTGCTAATATCAGG;
ALLP1 R (for 50 RACE)-CCTTCGAACTCTTCGC-
GTTA, Adaptor (Forward) primer was supplied by
Clontech; BLLP1 F-AAGGTCTTCACGAGATGCCA-
AC BLLP1 R-GCATCTGGAGATGTCTGGTAGGTT-
CTTC.
Following PCR conditions were used—94 1C, 2min—
initial denaturation, 35 cycles (94 1C—30 s, 60 1C—30 s,
72 1C—2min) and a final elongation at 72 1C for 10min.
Actin cDNA was amplified as an endogenous control. PCR
reaction components included: 1X buffer, 100 mM dNTPs,
1.5mM MgCl2, 0.5 units Taq polymerase (MBI), 0.5 mM
primers.2.2. Bacterial strains
BL21-CodonPlus strain (Stratagene) was used for
protein expression. For the antibacterial assays following
strains were procured from Microbial Type Culture
Collection (MTCC), Chandigarh, India: Klebsiella pneu-
moniae subsp.pneumoniae (MTCC no. 39), Serratia mar-
cescens (MTCC no. 86), Pseudomonas fluorescens (MTCC
no. 103), Bacillus thuringiensis subsp. Kurstaki (MTCC no.
868).
2.3. Phylogenetic analysis
Phylogenetic analysis was done by comparison of mature
full-length protein sequences of 35 insect lysozymes with
hen lysozyme (HL) as an outgroup. All the sequences were
aligned using ClustalX 1.8 and manually edited using
GeneDoc Version 2.6.002. The GenBank accession num-
bers for the sequences is provided as supplementary data
(Supplementary file 1). A neighbour-joining (NJ) tree was
constructed using HYPHY (Pond et al., 2005) and was
used as a base tree to test the best-fit model of evolution in
HYPHY. Akaike Information Criterion (AIC) was used to
select the best-fit model, which selected WAG (Whelan and
Goldman) model of amino acid substitution (Whelan and
Goldman, 2001). A maximum likelihood tree was con-
structed with the program TREE-PUZZLE 5.2 (Schmidt
et al., 2002) that utilized 50,000 quartet-puzzling steps.
2.4. Molecular weight (MW) and isoelectric pH (pI)
The MW and pI of the lysozymes were predicted using
the Expasy software. The SignalP software was used
to predict the signal peptide (Bendtsen et al., 2004)
(www.cbs.dtu.dk/services/SignalP/).
2.5. Real time PCR
A. mylitta and B. mori, 5th instar, day 3 larvae were
challenged with log phase E. coli or M. luteus as described
earlier (Gandhe et al., 2006). A set of larvae, injected with
sterile saline (mock infection) and a set of uninjected larvae
were used as control. Fat body total RNA was isolated by
Trizol method (Invitrogen) from the differentially chal-
lenged larvae and it was treated with RNAse free DNAse
(MBI) to remove genomic DNA contamination. Subse-
quently, cDNA was synthesized from 1 mg of total RNA
with oligo dT primers and MMLV reverse transcriptase
(Invitrogen). For quantitative PCR, the components
included the cDNA template; primers (0.5 mM) and SYBR
Green master mix (Eurogentec). PCR was carried out in
ABI Prism 7000 real time PCR cycler under following
conditions—50 1C—2min, 95 1C—10min and 40 cycles of
95 1C—15 s and 60 1C—1min. The fold increase of
lysozyme transcripts over the unchallenged levels was
calculated by the comparative Ct method (Applied
Biosystems). The data obtained were normalized against
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under similar conditions. The data presented are an
average of two independent reactions. Primers were
designed by Primer Express software (ABI) and their
sequences (50–30) were as follows:
AL F-GAGACAAGGCTTCGACGAGAG, AL R-TT-
GTTCACTTTACCAACTTTATCCGTAT;
ALLP1 F-CGATGGAAATTGTGCTCTAAAGG, AL-
LP1 R-TGCATCTGGCCACCCATT;
BL F-GGCTCGAAGGACTACGGATTG, BL R-CC-
GGACTGGCGCCTTT;
BLLP1 F-AGGGCGGAAATTGCAACAT, BLLP1
R-ATACCCGTTTTGCGCATCTAA;
Actin F-GGCATGGGACAGAAGGACT, Actin R-TA-
GTGACGATTCCGTGTTCG.
2.6. Recombinant expression, purification and refolding
AL and BL were cloned into pET-23a (+) and ALLP1
and BLLP1 were cloned in pET-28a (+) E. coli expression
vectors (Novagen). The NdeI and XhoI sites were
utilized to clone ALLP1 and BLLP1 downstream to the
N-terminal vector encoded histidine tag containing a
thrombin cleavage site for removal of histidine tag. NdeI
and NotI sites were used to clone AL and BL wherein an
N-terminal histidine tag was incorporated in the protein by
including it in the forward primer. The restriction sites
were incorporated in the primers and then the PCR
product was digested and ligated to the vector digested
with identical restriction enzymes. The clones were
confirmed by sequencing, recombinant plasmid was iso-
lated and transformed into BL21-CodonPlus strain (Stra-
tagene) of E. coli. The protein expression in BL21-
CodonPlus cells was induced by adding 0.8mM IPTG to
a log phase culture. The cells were harvested 6 h post
induction and the protein was purified from the inclusion
bodies under denaturing conditions. The N-terminal
histidine-tagged recombinant proteins were purified under
denaturing conditions (6M guanidium hydrochloride) by
affinity chromatography with Ni-NTA Agarose (Qiagen)
using the manufacturer’s protocol and the purified protein
was incubated with 5mM DTT at 4 1C overnight. The
denatured and reduced lysozymes were then refolded to
obtain a soluble active protein by dilution with refolding
buffer containing 1mM GSSG (oxidized glutathione)
and 0.1mM GSH (reduced glutathione), 264mM NaCl,
11mM KCl, 55mM Tris-HCl, pH 8.2; 1.1mM EDTA
(Lopez-Zavala et al., 2004). For ALLP1 and BLLP1,
1mM CaCl2 was added and EDTA was omitted from
the refolding buffer (Koshiba et al., 1999). The resulting
protein was concentrated using centricon columns
(Millipore) with a 10KD cut-off membrane, dialysed
against Milli Q water overnight. For ALLP1 and BLLP1,
dialysis was carried out with 1mM CaCl2 and 20mM Tris-
HCl, pH 8. The N-terminal histidine tag of ALLP1 and
BLLP1 was removed by thrombin (Novagen) digestion
according to the manufacturer’s protocol and the cleavedprotein was purified subsequently by size exclusion
chromatography using Superdex-200 (Amersham) col-
umns. Protein estimation was carried out by Bradford’s
method (Bradford, 1976).
2.7. Muramidase assay
Muramidase assay was carried out with M. luteus
substrate (Sigma) in 50mM sodium phosphate buffer, pH
6.5 and the absorbance at 450 nm was recorded after every
30 s. (Shugar, 1952). One unit of lysozyme is defined as the
amount that decreases the absorbance of the substrate
solution by 0.001 absorbance units /ml/min.
2.8. Peptidoglycan binding assay
Peptidoglycan binding assay was performed as described
earlier (Kang et al., 1998) with slight modifications. Briefly,
E. coli and M. luteus peptidoglycan (gift from Dr. Bruno
Lemaitre, Centre de Genetique Moleculaire, France) were
washed and resuspended in PBS (40 ml) and 10 mg of
ALLP1 and BLLP1 were added to it. After 30-min
incubation, the reaction components were pelleted down,
the pellet was washed once with PBS and the supernatant
and wash fractions were collected. The pellets were
resuspended in 40 ml PBS, boiled for 5min after addition
of 2X-SDS/PAGE loading buffer and analysed by western
blot. Appropriate controls were kept for the experiment.
Anti-histidine primary antibody (Qiagen) at 1:2000 dilu-
tion and anti-mouse IgG secondary antibody conjugated to
horseradish peroxidase (Amersham) at 1:2000 dilution was
used. The detection was done with ECL Plus detection
reagents (Amersham).
2.9. Antibacterial assays
2.9.1. Radial diffusion assay
The antibacterial activity of the purified proteins was
tested in a radial diffusion assay (Steinberg and Lehrer,
1997). The log phase bacteria were incorporated in an
underlay gel of 1% agarose in citrate phosphate buffer
(9mM sodium phosphate, 1mM sodium citrate, pH 6.0)
supplemented with 3% tryptic soy broth (TSB). Wells of
3mm diameter were bored into this underlay gel
and lysozymes and LLPs were added to each well and
allowed to diffuse for 3 h after which an overlay of 1%
agarose in citrate phosphate buffer supplemented with
6%TSB was overlaid on the lower gel and incubated
overnight at the ambient temperature. The zone of
bacterial inhibition was measured after incubation. The
bacterial strains used were—gram-negative: E. coli
MG1655, Salmonella typhi, Klebsiella pneumoniae and
Pseudomonas fluorescens and gram-positive: Staphylococ-
cus aureus, M. luteus, and Bacillus thuringiensis. The
inhibitory concentration (IC) was calculated from the
inhibition zone data using a formula (method (a)) valid for
inhibition zones smaller than critical diameter as described
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the present study because a curved plot of log n versus d2
was obtained with the series of concentrations used or in
case of a few bacterial species the inhibition zones were
obtained only with the highest concentration used in the
assay:
IC ¼ 0:468 n
ad2
;
wherein a is the thickness of agar layer (cm), d is the
inhibition zone diameter (cm) and n is the concentration in
nanomole of the antimicrobial protein utilized for the
assay, and IC is expressed in mM.
2.9.2. Kinetics of bacterial inhibition
The kinetics and bacteriostatic or bactericidal nature of
the antibacterial activity of BL and BLLP1 was determined
against E. coli and M. luteus by incubating the cells at a
concentration of approximately 104–105 cells/ml with
10 mM of the peptide in 1 X PBS (pH 6.5). Samples were
withdrawn at 1, 2, 4 and 8 h post incubation with
the AMPs and plated onto LB agar to determine the
viable colony forming units (cfu/ml). A control in which
cells were incubated with equivalent amount of sterile
water was also kept in parallel. For peptidoglycan
(peptidoglycan) competition assay, similar experiment
was carried out but BL and BLLP1 were pre-incubated
for 15min with 32 mg of M. luteus peptidoglycan (Sigma)
and then assayed for kinetics of inhibition against E. coli
and M. luteus as mentioned above.
2.10. Inner membrane (IM) permeabilization assay
IM permeabilization of E. coli strain MG1655 lacY:
Tn10dKan which is a lactose permease deficient strain was
estimated by analysing its b-galactosidase activity after
incubation with BL and BLLP1 (Steinberg and Lehrer,
1997). The cells were grown in poor LB broth (1%
bactotryptone, 0.9% NaCl) in the presence of 0.1mM
IPTG to log phase and 100 ml of bacterial suspensions
(106 cfu/ml) were incubated at 37 1C with BL and BLLP1,
respectively (10 mM). The samples were withdrawn at 1, 4
and 8 h post incubation, centrifuged and the supernatants
were stored at 20 1C. The b-galactosidase activity of the
samples was assayed with ONPG as the substrate and the
absorbance was read at 420 nm. As a control, cells
incubated with sterile water were assayed for b-galactosi-
dase activity.
2.11. Preparation of dsRNA and RNAi
BLLP1 cDNA (357 bp) was cloned into pCRII-TOPO
vector (Invitrogen) and amplified with M13 forward and
reverse primers. This template with flanking T7 and SP6
promoters was utilized for in vitro transcription reaction
and sense and antisense RNA strands were generated with
the T7 and SP6 Megascript kits (Ambion). The DNAtemplate was removed from the transcripts by DNAse
treatment and the RNA products were subsequently
purified by Trizol extraction (Invitrogen) followed by
isopropanol precipitation. The complementary single
stranded RNAs were dissolved in DEPC treated water,
combined in equimolar amounts in 1X insect buffer
saline (IBS, composition: NaCl—160mM, KCl—10mM,
CaCl2—4mM) and annealed by heating to 95 1C and slow
cooling overnight at room temperature. Similarly, dsRNA
specific to green fluorescent protein (GFP) was synthesized
as a non-specific control. The dsRNA formation was
confirmed by agarose gel electrophoresis and the concen-
tration was determined spectrophotometrically. To deter-
mine the in vivo role of BLLP1 in immunity, we knocked
down the BLLP1 expression by RNAi and then assessed
the effects on immune function by an experiment
mentioned below.2.12. In vivo bacteria clearance assay
The ability of clearance of bacteria injected in larvae
systemically was assessed and compared with that obtained
from RNAi-mediated BLLP1 knockdown larvae. For
bacterial clearance assay, dsRNA specific for BLLP1
(1 mg per larva) or 1X IBS (control) or GFP-dsRNA
(control) was injected to a set of 5 B. mori larvae
followed by an E. coli MG1655 injection (approximately
106 cells), 6 h later. 18-hour post E. coli-challenge, the
hemolymph was aseptically collected in pre-chilled eppen-
dorf tubes containing phenylthiourea crystals and the
hemocytes were pelleted by centrifugation at 2000 rpm. The
supernatant plasma of 100 ml was plated on LB agar plates,
incubated overnight at 37 1C and colony-forming units
(cfu/ml) were estimated. As a control, the clearance of
bacteria in saline-injected and GFP-dsRNA injected larvae
was analysed.3. Results
3.1. Isolation of LLP and lysozyme cDNAs
A full-length cDNA of a lysozyme-like transcript from
an immune challenged fat body library of A. mylitta was
obtained as described in the experimental procedures. The
deduced amino acid sequence revealed 52% similarity at
the amino acid level with A. mylitta c-type lysozyme
(AL) but there was a substitution at the catalytically
essential aspartate-50 residue by a tyrosine residue (Fig. 1).
We designated the new protein as A. mylitta lysozyme-like
protein 1 (ALLP1). The BLAST search of B. mori genomic
(Wang et al., 2005) and EST database (Mita et al.,
2003) with ALLP1 as a query sequence, led to the
identification of three additional B. mori lysozyme-like
transcripts (BLLPs) which too lacked both the catalytic
amino acid residues. We designated them as BLLP1, 2 and
3, respectively.
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Fig. 1. Comparison of LLP and lysozyme sequences from silkmoths. Multiple alignment of amino acid sequences of A. mylitta LLP and lysozyme
(ALLP1 and AL, respectively), B. mori LLPs and lysozyme (BLLP1, BLLP2, BLLP3 and BL, respectively) and hen lysozyme (HL). The position of two
catalytic residues, Glu-32 and Asp-49 is indicated by () symbol and note that the corresponding residues in LLPs are substituted. Fully conserved
residues are shaded in grey.
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lysozymes
The gene structure of BL and the three BLLPs as
obtained from the B. mori genome sequence and its
comparison with HL gene is shown in Supplementary file
2. Gene structure comparison suggests an overall correla-
tion between BL, BLLPs andHL with reference to location
of exons/introns and amino acid residues interrupted at the
introns, with the only exception of BLLP2, which is
encoded by a single exon. The similarity in the gene
organization between BL, BLLPs and HL suggests a
common origin for lysozymes and LLPs.
The amino acid comparison of LLPs with c-type
lysozymes revealed that LLPs lack either one or both of
the catalytic amino acids with the exception of BLLP2
(Fig. 1). However, the substrate binding residues were
found to be conserved. Of the 12 substrate binding sites
identified in insect lysozymes (Jain et al., 2001), 4 were
conserved in all the three LLPs-ALLP1, BLLP1, BLLP3
while 7 were partially conserved (conserved in either one or
two of the three LLPs). Comparison of the MW/pI of the
silkworm lysozymes, LLPs and HL is represented in
Supplementary file 3. BLLP2 is unique with respect to
other LLPs and resembled an Anopheles lysozyme (c-6) and
a Drosophila lysozyme that comprises of multiple lysozyme
domains. A signal peptide was predicted with the SignalP3.0 software in all the silkworm LLPs suggesting their
secretory nature. We generated an in-silico tertiary
structure of ALLP1 and BLLP1 based on the BL 3-D
structure (PDB entry: 1GD6). The superimposition of
ALLP1 and BLLP1 with BL (Supplementary file 4)
revealed that the overall structure and positions of the
four-disulphide bonds is conserved but a few variations
especially in the secondary structural elements were found.
Thus, the amino acid substitutions at catalytic site do not
seem to alter the 3-D structure of LLPs though it abolishes
the muramidase activity.
3.3. Phylogenetic analysis clusters LLPs and lysozymes into
distinct groups
Phylogenetic analysis clustered silkmoth LLPs with a
few similar dipteran proteins from Drosophila and Ano-
pheles, which also incidentally lacked one or both the
catalytic amino acid residues (Fig. 2). However, conven-
tional dipteran and lepidopteran lysozyme sequences with
conserved catalytic amino acid residues formed two distinct
groups in the phylogenetic tree and did not group with
LLPs. BLLP2 and HL did not group with any other insect
lysozymes or LLPs.
In the present study, we confined our functional analysis
to ALLP1 and BLLP1, as representatives of this LLP
family in silkmoths.
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Fig. 2. Maximum likelihood phylogenetic tree constructed from 35 insect full-length lysozyme sequences with hen lysozyme (Gallus gallus) as an outgroup.
BLLP2 partial sequence that aligned with insect lysozymes and silkmoth LLPs was taken for analysis. The bootstrap values are represented as a percentage
at the branch nodes. The branch lengths are proportional to the amino acid substitutions. The GenBank accession numbers for all the sequences can be
found in the Supplementary file 1. The silkmoth lysozymes and LLPs are marked with closed squares and triangles, respectively. Scale shows 0.2 amino
acid substitutions per site.
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Expression profile of ALLP1 and BLLP1 with AL
and BL in E. coli andM. luteus challenged 5th instar larval
fat body tissues was examined quantitatively. AL and
ALLP1 were moderately upregulated (3–4 fold) upon
M. luteus-challenge, and highly induced (15–20 fold)
upon E. coli-challenge (Fig. 3). BL and BLLP1 also
exhibited similar changes but induction of BLLP1
was less (2.7 fold) upon E. coli-challenge. We also
confirmed their immune upregulation in other tissues
from 5th instar immune-challenged A. mylitta and
B. mori larvae by semi-quantitative RT-PCR (Supplemen-
tary file 5). The expression pattern of BLLP1 and
BL in different embryonic stages of B. mori as analysed
by semi-quantitative RT-PCR is also shown in Supple-mentary file 5. BL was not expressed at the 45-h
stage, increasing gradually in later stages. BLLP1
was expressed prominently throughout the five stages
analysed suggesting a probable function during embryonic
development.
3.5. Protein expression, purification and refolding
AL, BL, ALLP1 and BLLP1 were expressed as inclusion
bodies in BL-21 CodonPlus E. coli expression system
and were purified under denaturing conditions by affinity
chromatography. The purified proteins were then
refolded and 6x histidine tag was cleaved followed by re-
purification with Superdex-200 gel filtration. However,
the presence of histidine tag was not found to alter the
activity of proteins (not shown). Hence the histidine tagged
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Fig. 3. Real time PCR profile of (a) AL and ALLP1 and (b) BL and
BLLP1 in fat body from differentially challenged 5th instar, day 3 larvae.
The Y-axis represents the fold increase of the transcripts over the
unchallenged levels. The values reported are an average of two
independent experiments and the standard deviation is represented as
the Y error bar. X-axis represents the four differentially challenged larval
groups—1. Unch, unchallenged, 2. Saline; 3. ML-Micrococcus luteus; and
4. EC, E. coli.
Fig. 4. Peptidoglycan binding assay of ALLP1 and BLLP1 withM. luteus
and E. coli insoluble peptidoglycan. The bound (B) and free (F) fractions
were obtained as described in the text. All the samples were run on a 12%
SDS-PAGE gel and ALLP1 and BLLP1 proteins were detected by western
blot using anti-histidine antibodies. A control containing only ALLP1 or
BLLP1 without peptidoglycan was treated in the same manner as the test
samples and bound and free fractions were analysed. EC, E. coli, ML,
M. luteus.
Table 1
Muramidase activity of silkmoth lysozymes (AL, BL) and lysozyme-like
proteins (ALLP1, BLLP1)
Lysozyme/LLP Specific activity (U/mg)
AL 1565871117
BL 115727241
ALLP1 No activity
BLLP1 No activity
A.S. Gandhe et al. / Insect Biochemistry and Molecular Biology 37 (2007) 655–666 661proteins were used for functional assays. The homogeneity
and specificity of recombinant LLPs was confirmed by
gel filtration, SDS-PAGE (Supplementary file 6) and
western blot (not shown). The estimated MW of ALLP1
and BLLP1 were 29.47 and 19.61 kDa, respectively,
which is slightly higher than the predicted MW of both
the recombinant proteins. This is also true with the
silkworm lysozymes, wherein estimated MW was found
to be higher than the predicted MW. ALLP1 is a larger
protein than BLLP1 and possesses 39 extra amino acids at
the C-terminal end. Refolding was assessed by CD
spectroscopy and the estimated secondary structure was
in agreement with the in-silico predicted structure (Supple-
mentary file 7).3.6. LLPs lack muramidase activity but exhibit substrate
binding property
The spectrophotometric assay for muramidase activity
utilizes the lyophilized M. luteus as a substrate and the
activity is monitored by a decrease in the turbidity upon
addition of the enzyme. Assay results (Table 1) show that
ALLP1 and BLLP1 lack muramidase activity even at 10
times higher protein concentration over AL and BL, which
exhibited a specific activity of 15,657 and 11,571U/mg,
respectively. This confirmed the ablation of muramidase
activity in LLPs as predicted from the substitutions at the
catalytic residues (Malcolm et al., 1989).
Both ALLP1 and BLLP1 were observed to bind
peptidoglycan, the characteristic lysozyme substrate, when
analysed by western blot analysis (Fig. 4). This confirms
that the LLPs bind to peptidoglycan although they are
unable to hydrolyse it unlike classical lysozymes.
3.7. LLPs exhibit antibacterial activity
Both ALLP1 and BLLP1 inhibited a wide range of
bacterial species including both gram-positive and gram-
negative bacteria in the radial diffusion assay (Fig. 5).
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Fig. 5. Radial diffusion antibacterial assay of AL, ALLP1, BL, and BLLP1. Antibacterial activity of the purified proteins was assayed against three gram-
positive (Micrococcus luteus, Staphylococcus aureus, Bacillus thuringiensis) and four gram-negative (E. coli, Klebsiella pneumoniae, Pseudomonas
fluorescens, Salmonella typhi) bacteria. The zone of inhibition is plotted on the Y-axis and the different bacterial species are indicated on X-axis.
Table 2
Inhibitory concentration (IC) of lysozymes and LLPs
Bacteria IC (mM)
AL ALLP1 BL BLLP1
Gram-positive
Micrococcus luteus 0.57 0.77 1.62 1.06
Staphylococcus aureus 0.49 0.93 0.81 1.67
Bacillus thuringiensis 0.81 5.20 2.40 5.20
Gram-negative
Escherichia coli 0.67 0.93 1.29 2.11
Pseudomonas fluorescens 23.4 2.22 17.33 3.29
Salmonella typhi 6.68 2.72 8.5 2.34
The IC value was calculated from the inhibition zone data as described in
the experimental procedures. The IC value against various gram-positive
and gram-negative bacteria tested is mentioned.
A.S. Gandhe et al. / Insect Biochemistry and Molecular Biology 37 (2007) 655–666662Similar to the silkworm lysozymes, ALLP1 and BLLP1
also showed a higher activity against the gram-positive
bacteria than the gram-negative bacteria. However, the
only exception to this trend is E. coli against which all the
four proteins exhibited activity comparable to that against
the other gram-positive bacteria. The IC values of all the
four proteins are presented in Table 2.
Since bacterial growth inhibition indicates either bacter-
iostatic or bactericidal action, the viability of E. coli (gram-
negative bacterial species) and M. luteus (gram-positive
bacterial species) was determined at different time
points after treatment with BL and BLLP1. Fig. 6a and b
indicate the kinetics of antibacterial action of BL and
BLLP1 against E. coli and M. luteus, respectively. BLLP1
exerts a bacteriostatic effect on both the bacteria and no
killing was observed even after an 8-h incubation as against
BL, which reduced the viable bacterial count, by 2–3 log
scale (Fig. 6).The mechanism of lysozyme action is well studied. It
involves peptidoglycan hydrolysis that results in osmotic lysis
of bacteria. The bacterial membrane is the site of anti-
microbial action of many other vertebrate and invertebrate
AMPs as exemplified by cecropins, magainins and defensins
(Bulet et al., 2004). These AMPs permeabilize the IM of
bacteria by forming pores leading to rapid death of the
organism. IM permeabilization of lysozymes and LLPs was
assayed by measuring the b-galactosidase activity of
E. coli samples incubated with BL and BLLP1 (Fig. 7).
b-galactosidase is located in the cytosol and hence will only be
detected if the bacterial cell membrane is permeabilized. Fig. 7
shows that b-galactosidase activity increased in bacterial
samples incubated with BL reaching a maximum at 4h post
incubation with BL. Though the mechanism of lysozyme
action involves peptidoglycan hydrolysis, the cells subse-
quently lyse due to the osmotic pressure as an indirect effect
of peptidoglycan hydrolysis thereby releasing the cytoplasmic
contents. However, no b-galactosidase activity was detected
in the bacterial samples incubated with BLLP1 even at 8h
post incubation indicating that they neither hydrolyse the
peptidoglycan like conventional lysozymes nor do they
permeabilize the cell membrane like many other AMPs as
has been demonstrated before (Steinberg and Lehrer, 1997).
The ability of LLPs to bind the peptidoglycan substrate
and its higher activity against gram-positive bacteria
pointed towards involvement of peptidoglycan binding as
a possible mechanism of antibacterial action. We observed
that the inhibitory activity of BLLP1 against E. coli and
M. luteus was actually rescued in the presence of
peptidoglycan indicating that growth inhibition primarily
involves peptidoglycan binding (Fig. 6). Bacteria-binding
proteins opsonize bacteria and agglutinate them and this
may cause error in counting the bacteria by colony count
method. However, this possibility was ruled out as
agglutination of bacteria was not observed post treatment
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Fig. 6. Kinetics of viability of E. coli (a) andM. luteus (b) at different time points post incubation with BL and BLLP1. The log10 value of colony forming
units (cfu/ml) is plotted on the Y-axis and the time period of incubation with the proteins is shown on the X-axis. A control in which the bacteria were
incubated with equivalent amount of PBS and a competition assay in which BLLP1 was pre-incubated with peptidoglycan was also done.
Fig. 7. Kinetics of inner membrane (IM) permeabilization of E. coli by BL and BLLP1. The IM permeabilization was determined by a spectrophotometric
assay as explained in experimental section by measuring the b-galactosidase activity of E. coli samples incubated with BL and BLLP1 using a
spectrophotometric assay. The absorbance is plotted on Y-axis, which is proportional to the b-galactosidase activity and the incubation time of bacterial
samples with BL and BLLP1 is shown on X-axis.
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(data not shown). Thus at this stage it indicates that
peptidoglycan binding is indeed involved in the antibacter-
ial action though it is not known whether peptidoglycan
binding itself renders the antibacterial effect or some other
process is inhibited consequent to peptidoglycan binding.
3.8. In vivo functional analysis by RNAi
Previous reports have shown that immunity is mediated
by secretion in the hemolymph of recognition proteins and
effector antimicrobial proteins upon immune challenge.
Hence we analysed the clearance of E. coli from
hemolymph in BLLP1 knockdown insects as comparedto larvae injected with non-specific dsRNA (GFP-dsRNA)
or saline prior to E. coli-challenge. Fig. 8a indicates that E.
coli load was 3–4 fold higher in BLLP1 knockdown larvae
as compared to the control larvae. The BLLP1-dsRNA
induced knockdown of BLLP1 was confirmed at molecular
level by RT-PCR and is shown in Fig. 8b. This indicates
the involvement of BLLP1 in immunity and point towards
its occurrence in hemolymph as predicted from the signal
peptide studies.
4. Discussion
We have characterized a novel family of antibacterial
proteins, ALLP1 and BLLP1 in the present study and also
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Fig. 8. In vivo functional analysis of BLLP1 by RNAi. (a) Bacteria clearance assay: Colony forming units/ml of E. coli in the hemolymph of BLLP1-
dsRNA injected and control (GFP-dsRNA injected and saline) larvae. The data represented are an average of two independent experiments with a set of 5
larvae in each group. The standard deviation is represented as Y error bars. (b) RT-PCR analysis from fat body of BLLP1 knock down (BLLP1-dsRNA
injected) and control (saline-injected and GFP-dsRNA injected) larvae. Actin is used as an endogenous control.
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which need to be further analysed functionally. BLLP3
probably resembles ALLP1 and BLLP1 functionally due to
high degree of similarity among them. Moreover, the EST
database of B. mori (Mita et al., 2003) revealed that BLLP3
was expressed in the fat body of larval and pupal stages
and also found in the baculovirus-challenged fat body
tissue of B. mori. However, BLLP2 was very different from
the other LLPs and c-type lysozymes and resembled the
multidomain LLPs, c-6 from A. gambiae and one
Drosophila lysozyme. Also, it was found to be expressed
in the pheromone gland in the B. mori EST database
suggesting that it may be involved in a different function
altogether.
The insect immune repertoire elicits an impressive array
of antimicrobial proteins that enable a strong effector
response to successfully ward off infections during their
lifetime. The immune-upregulation and the in vitro and in
vivo functional analyses suggest that LLPs are antibacterial
proteins, which play an important role in immune
response. There are evidences in literature demonstrating
the antibacterial nature of catalytically inactive mutant
lysozymes (Nash et al., 2006; Ibrahim et al., 2001). We,
however, present a first report of naturally occurring
muramidase deficient antibacterial c-type LLPs from
insects. Ibrahim et al. (2006) have shown earlier that a
catalytically inactive Asp-52-Ser hen mutant lysozyme
possesses bactericidal activity against S. aureus and
B. subtilis (Ibrahim et al., 2001) and recently Nash et al.
(2006) have demonstrated the in vivo killing properties of
Asp-52-Ser, a mutant mouse lysozyme against S. aureus,
K. pneumoniae and P. aeruginosa. Our results on the other
hand show that BLLP1 inhibits the growth of E. coli and
M. luteus and does not kill them. Previous work on non-
catalytic lysozyme mutants has led to three probable
mechanisms to explain the antibacterial action: (1) lysis of
cells due to binding of lysozyme to a potential target
inducing autolysin mediated death, (2) membrane permea-
bilization leading to cell lysis and (3) non-lysis mediatedmode due to interference of membrane function as a
consequence of lysozyme binding at the surface (Ibrahim
et al., 2001). Our study corroborates the last theory as
exemplified by BLLP1, which neither permeabilizes the IM
nor causes lysis. Moreover, the ability of the catalytically
inactive LLPs to bind peptidoglycan and their higher
activity towards gram-positive bacteria point towards
peptidoglycan as the possible site of antibacterial action.
The rescue of the bacterial inhibition upon incubation with
peptidoglycan indeed points towards involvement of
peptidoglycan binding as a requirement for antibacterial
mechanism. Though the site of action of LLPs as well as
lysozymes appears to be peptidoglycan, the mechanism
appears to be different as the LLPs lack peptidoglycan
hydrolysis property. Peptidoglycan layer is surrounded by
an outer membrane in gram-negative bacteria making them
less-accessible to AMPs acting on peptidoglycan and this
trend also is well reflected by LLPs which are preferentially
more active against gram-positive bacteria. We speculate
that the bacterial inhibition is due to the binding of LLPs
to bacterial surface and subsequently interfering with its
normal physiology. One possibility is that the LLPs bind
peptidoglycan precursors and hence compete with the
peptidoglycan synthesis machinery thereby affecting its
growth. Our hypothesis is supported by a recent report
indicating bacteriostatic and bactericidal properties of
human peptidoglycan recognition proteins, another class
of peptidoglycan binding proteins (Lu et al., 2006).
However, the mechanisms of antibacterial action remain
speculative at this juncture and merit further analysis.
The roles of several immune proteins have been analysed
by RNAi mediated knockdown in the recent studies
(Kambris et al., 2006; Foley and O’Farrell, 2004). We, in
this study show an increased proliferation of bacteria in
BLLP1 knockdown larvae. Insect immune repertoire
comprises of several antibacterial proteins and hence effects
of knockdown of a single AMP on the bacterial prolifera-
tion are intriguing. However, different immune pathways
exhibit a complex network and involve cooperative roles of
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involved in other functions in addition to the antibacterial
effector function. For example, human peptidoglycan
recognition proteins have recently been shown to function
as both recognition and antibacterial proteins (Lu et al.,
2006). The immune role of LLPs is established by these
analyses but a further study is required to probe its exact
role in the immune system. A strong expression of
transcripts at the embryonic stages also suggests a possible
role in development. Many immune related protein
molecules, for example, hemolin has been shown to have
a dual role in immunity as well as development (Bettencourt
et al., 2002) and hence other functions cannot be ruled out.
The current studies present a first report of a functional
analysis of a novel class of LLPs lacking muramidase
activity from insects. The functional annotation of this new
group of lysozymes likely provides cues for analysis of their
homologues in other organisms. For example, two human
c-type LLPs lacking catalytic residues have been recently
reported (Zhang et al., 2005) whose function may be
elucidated in the light of the insect LLPs reported in the
present study.
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